Table 3.
Variables significantly related to concentric LV geometry and impairment of circumferential and longitudinal components of LVSD in the 194 normotensive patients with RA
| 194 Normotensive Patients With RA | OR | 95% CI | P Value |
|---|---|---|---|
| Concentric LV geometry | |||
| sc‐MS | 0.91 | 0.88–0.94 | <0.001 |
| E/e' | 1.39 | 1.02–1.91 | 0.04 |
| BMI | 1.10 | 1.00–1.21 | 0.04 |
| CRP | 1.00 | 0.94–1.08 | 0.79 |
| Age | 1.02 | 0.98–1.06 | 0.40 |
| Impaired circumferential component of LV systolic function (low sc‐MS) | |||
| Male sex | 2.45 | 1.23–4.80 | 0.01 |
| CRP | 1.08 | 1.00–1.17 | 0.04 |
| E/e' | 0.83 | 0.64–1.07 | 0.16 |
| LV mass | 1.03 | 0.99–1.06 | 0.13 |
| Impaired longitudinal component of LV systolic function (low GLS) | |||
| GFR | 1.04 | 1.01–1.07 | 0.01 |
| Age | 1.07 | 1.00–1.14 | 0.03 |
| CRP | 0.76 | 0.56–1.04 | 0.09 |
Abbreviations: BMI, body mass index; CI, confidence interval; CRP, C‐reactive protein; GFR, glomerular filtration rate; GLS, global longitudinal strain; LV, left ventricular; LVSD, left ventricular systolic dysfunction; OR, odds ratio; RA, rheumatoid arthritis; sc‐MS, stress‐corrected midwall shortening.